IL59425A - Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation - Google Patents

Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation

Info

Publication number
IL59425A
IL59425A IL59425A IL5942580A IL59425A IL 59425 A IL59425 A IL 59425A IL 59425 A IL59425 A IL 59425A IL 5942580 A IL5942580 A IL 5942580A IL 59425 A IL59425 A IL 59425A
Authority
IL
Israel
Prior art keywords
compounds
preparation
certain
carboxylic acid
pharmaceutical compositions
Prior art date
Application number
IL59425A
Other languages
English (en)
Other versions
IL59425A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL59425A0 publication Critical patent/IL59425A0/xx
Publication of IL59425A publication Critical patent/IL59425A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL59425A 1979-02-21 1980-02-19 Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation IL59425A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792906603 DE2906603A1 (de) 1979-02-21 1979-02-21 N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
IL59425A0 IL59425A0 (en) 1980-05-30
IL59425A true IL59425A (en) 1984-05-31

Family

ID=6063481

Family Applications (1)

Application Number Title Priority Date Filing Date
IL59425A IL59425A (en) 1979-02-21 1980-02-19 Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation

Country Status (19)

Country Link
US (2) US4397848A (cs)
EP (1) EP0014976B1 (cs)
JP (1) JPS55113760A (cs)
AR (1) AR223863A1 (cs)
AT (1) ATE818T1 (cs)
AU (1) AU529982B2 (cs)
CA (1) CA1148962A (cs)
CS (1) CS208798B2 (cs)
DD (1) DD148772A5 (cs)
DE (2) DE2906603A1 (cs)
ES (1) ES488656A1 (cs)
FI (1) FI70702C (cs)
HU (1) HU182801B (cs)
IE (1) IE49267B1 (cs)
IL (1) IL59425A (cs)
PL (1) PL129707B1 (cs)
PT (1) PT70847A (cs)
SU (1) SU1181541A3 (cs)
ZA (1) ZA80902B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
JPH07301287A (ja) * 1995-03-23 1995-11-14 Sumitomo Heavy Ind Ltd 制御装置に用いられる内接噛合遊星歯車機構
ATE252381T1 (de) * 1997-06-27 2003-11-15 Amplimed Inc Neue cyanoaziridine zur behandlung von krebs
AU2002216672A1 (en) * 2000-11-21 2002-06-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Composition comprising an imexon or derivatives thereof and lipids
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
ES2294197T3 (es) * 2001-12-21 2008-04-01 Supernus Pharmaceuticals, Inc. Formulacion de capsula oral con estabilidad fisica aumentada.
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
NZ540612A (en) 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
PL378295A1 (pl) * 2003-02-24 2006-03-20 Arena Pharmaceuticals, Inc. Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu glukozy oraz profilaktyka i leczenie zaburzeń tego metabolizmu
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
WO2005121121A2 (en) * 2004-06-04 2005-12-22 Arena Pharmaceuticals, Inc. Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
WO2007035355A2 (en) * 2005-09-16 2007-03-29 Arena Pharmaceuticals, Inc. Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
WO2011094008A1 (en) 2010-01-27 2011-08-04 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
EP2619198A1 (en) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP4445956A2 (en) 2015-01-06 2024-10-16 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
WO2016209809A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
CN113816887A (zh) * 2021-08-31 2021-12-21 华中科技大学 一种氮杂环丙烷类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2644820A1 (de) * 1976-10-05 1978-04-06 Boehringer Mannheim Gmbh Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
DE2731264A1 (de) 1977-07-11 1979-02-01 Boehringer Mannheim Gmbh Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
JPS55113760A (en) 1980-09-02
IE800327L (en) 1980-08-21
FI70702C (fi) 1986-10-06
PL222088A1 (cs) 1980-12-01
ES488656A1 (es) 1980-09-16
DD148772A5 (de) 1981-06-10
CA1148962A (en) 1983-06-28
AU529982B2 (en) 1983-06-30
SU1181541A3 (ru) 1985-09-23
US4517183A (en) 1985-05-14
US4397848A (en) 1983-08-09
HU182801B (en) 1984-03-28
ZA80902B (en) 1981-03-25
AU5564980A (en) 1980-08-28
EP0014976A1 (de) 1980-09-03
DE3060268D1 (en) 1982-05-19
PL129707B1 (en) 1984-06-30
EP0014976B1 (de) 1982-04-07
PT70847A (de) 1980-03-01
IE49267B1 (en) 1985-09-04
FI70702B (fi) 1986-06-26
FI800510A (fi) 1980-08-22
AR223863A1 (es) 1981-09-30
JPH0150700B2 (cs) 1989-10-31
CS208798B2 (en) 1981-09-15
ATE818T1 (de) 1982-04-15
IL59425A0 (en) 1980-05-30
DE2906603A1 (de) 1980-09-04

Similar Documents

Publication Publication Date Title
DE3071939D1 (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
IL62018A0 (en) Agmatine derivatives,their preparation and pharmaceutical compositions containing them
IL60129A0 (en) Phenylsulphonamide derivatives,their preparation and pharmaceutical compositions containing them
IL59425A (en) Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation
DE3068678D1 (en) 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
GB2053909B (en) Pyrrolidinylalkycarboxylic acid amide derivatives their preparation and pharmaceutical compositions containing them
DE3062216D1 (en) Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
IL59770A (en) Pharmaceutical compositions containing 3-alkoxy-flavone derivatives,some novel compounds of this type and their preparation
IL61481A0 (en) Piperidylbenzimidazolinone derivatives,their preparation and pharmaceutical compositions containing them
IL61264A (en) Dihydro-piperazinylpyrazolobenzodiazepine compounds,their preparation and pharmaceutical compositions containing them
IL59444A0 (en) Imidazole derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
IL60472A0 (en) Substituted heterocyclic phenoxy-amines,their preparation and pharmaceutical compositions containing them
DE3065460D1 (en) Benzocycloheptapyrrolealkanoic acids and their derivatives, processes for their preparation and pharmaceutical compositions containing them
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
ZA793966B (en) N-substituted aziridine-2-carboxylic acid derivatives,processes for their preparation,and pharmaceutical compositions thereof
IL60359A (en) Dialkylaminoalkoxyiminocycloalkane derivatives,their preparation and pharmaceutical compositions containing them
IL60058A0 (en) Hydroxyamino-eburnane derivatives,their preparation and pharmaceutical compositions containing them
DE3067784D1 (en) 2-hydroxyoxanilic acid derivatives and salts, their preparation and pharmaceutical compositions containing them
IL60813A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL61580A0 (en) Heterocyclic compound,its preparation and pharmaceutical compositions containing it
DE3062972D1 (en) Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
IL60927A (en) Amino-propanoloxytetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL61675A0 (en) N-substituted -amino acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL60548A0 (en) Ergol-8-ene and ergolin derivatives,their preparation and pharmaceutical compositions containing them